Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Psychiatry

Edition
Latest

30-Second Takeaway

  • Adults with incident cancer have substantially increased risk of new mental disorders, especially in the first year.
  • Inpatient LAI selection and discharge complexity predict readmission risk beyond medication choice.

Latest - Week ending May 2, 2026

Five recent studies with immediate clinical signals: cancer-associated incident mental disorders, adolescent antistigma plus primary-care intervention, VR versus standard CBTp moderators, LAI choice and readmission, and冬

Incident cancer confers roughly 2.3-fold higher risk of new mental disorders versus matched controls

BRITISH JOURNAL OF CANCERApr 30, 2026

In a Danish register cohort of 289,391 cancer patients and 1,031,057 matched controls, 116,118 developed a new mental disorder. Overall hazard ratio for any incident mental disorder was 2.3 (95% CI reported as 2.3–2.3). Risks peaked in the first year after diagnosis and remained elevated beyond ten years, with highest rates for anxiety, depression, and substance use disorders. Findings were consistent across sensitivity analyses but varied by cancer type, sex, and time since diagnosis.

Multimedia antistigma plus primary-care digital intervention modestly improved adolescent attitudes and depressive symptoms

JAMA PSYCHIATRYApr 29, 2026

ARTEMIS randomized 60 slum clusters (3,739 adolescents; 1,761 high-risk) to an antistigma campaign plus primary-care digital care versus usual care. Mean behavior (attitude/intended behavior) scores increased modestly (difference ≈0.78) favoring the intervention. Among high-risk adolescents, PHQ-9 score change favored intervention (4.05 vs 4.92) and remission numerically improved but was not statistically significant. Implementation fidelity was high and primary-care physicians saw 87% of the high-risk intervention cohort.

VR-CBTp may benefit patients with high avolition or moderate-to-high delusion severity

PSYCHOLOGICAL MEDICINEApr 27, 2026

Exploratory moderator analysis of the FaceYourFears trial (n=254) compared VR-based CBTp versus standard CBTp for paranoia. Higher baseline avolition and delusion severity predicted poorer outcomes overall, but patients with high avolition or moderate-to-high delusion severity improved more with VR-CBTp than with standard CBTp. No demographic factors significantly modified outcomes, and most moderators showed modest or nonsignificant effects. Authors conclude both treatments remain broadly suitable and that VR-CBTp is hypothesis-generating rather than definitive.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Screen recently diagnosed cancer patients early and repeatedly for anxiety, depression, and substance use.
  • When starting LAIs at discharge, document illness severity and coordinate intensive discharge planning.
  • Consider VR-CBTp for patients with high avolition or moderate-to-high delusion severity, but discuss limited evidence.